Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Estrogen Supplementation and Bone Health in Women With CF (STURDY)

Trial Profile

Estrogen Supplementation and Bone Health in Women With CF (STURDY)

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Nov 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Estradiol (Primary) ; Progesterone
  • Indications Cystic fibrosis
  • Focus Therapeutic Use
  • Acronyms STURDY

Most Recent Events

  • 21 Nov 2023 Planned End Date changed from 1 Dec 2024 to 1 Dec 2025.
  • 21 Nov 2023 Planned primary completion date changed from 1 Dec 2024 to 1 Dec 2025.
  • 18 Apr 2023 Planned initiation date (estimated date of first participant enrollment) changed from 1 Apr 2023 to 1 Jun 2023.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top